Oncology Medical News about antiphospholipid syndrome

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Management of the antiphospholipid syndrome: new approaches
International Journal of Clinical Rheumatology, 10/19/09

Seif AM et al. – The antiphospholipid syndrome (APS) is an autoimmune, multisystemic disorder associated with recurrent thrombosis (arterial and/or venous) and pregnancy loss, among other clinical manifestations. These new treatments – potentially more effective and with fewer side effects – might be used in the future to treat clinical manifestations of this disease that are associated with devastating consequences, and are pending adequate clinical trials.

<< Previous
Using an RNA aptamer probe for flow cytometry detection of...

Next >>
Location of the Primary Tumor is Not an Independent Predictor of...

Common infectious agents prevalence in antiphospholipid syndrome
Lupus, 11/05/09 Relevance Score: 70%

The Cardiac Manifestations of Antiphospholipid Syndrome and Their Echocardiographic Recognition
Journal of The American Society of Echocardiography, 10/09/09 Relevance Score: 69%

Catastrophic antiphospholipid syndrome in a patient with Down syndrome
Lupus, 10/05/09 Relevance Score: 68%

Antiphospholipid antibodies and risk of myocardial infarction and ischaemic stroke in young women in the RATIO study
The Lancet Neurology, 10/16/09 Relevance Score: 66%

Right atrium myxoma coexisting with antiphospholipid syndrome
Cardiovascular Ultrasound, 10/12/09 Relevance Score: 66%